Drug class
Barbiturate sedative-hypnotic; positive allosteric modulator of GABAA receptors (historical)
Mechanism of action
Enhances GABA-mediated chloride-channel opening at GABAA receptors and can directly activate the channel at higher concentrations, producing central nervous system depression.
General use cases
- Historical short-term treatment of insomnia and anxiety in countries where cyclobarbital was marketed; use has been discontinued or restricted in many jurisdictions because of dependence, overdose and respiratory-depression risk
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
